Long-Lasting Exendin-4 Fusion Protein Improves Memory Deficits in High-Fat Diet/Streptozotocin-Induced Diabetic Mice

Glucagon-like peptide 1 (GLP-1) mimetics have been approved as an adjunct therapy for glycemic control in type 2 diabetic patients for the increased insulin secretion under hyperglycemic conditions. Recently, it is reported that such agents elicit neuroprotective effects against diabetes-associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Kyung-Ah, Jin, Zhen, Lee, Jong Youl, An, Hyeong Seok, Choi, Eun Bee, Kim, Kyung Eun, Shin, Hyun Joo, Jeong, Eun Ae, Min, Kyoung Ah, Shin, Meong Cheol, Roh, Gu Seob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076426/
https://www.ncbi.nlm.nih.gov/pubmed/32079069
http://dx.doi.org/10.3390/pharmaceutics12020159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076426/
https://www.ncbi.nlm.nih.gov/pubmed/32079069
http://dx.doi.org/10.3390/pharmaceutics12020159

Ejemplares similares